{"id":"https://openalex.org/W2054444951","doi":"https://doi.org/10.1208/s12249-014-0221-9","title":"A Risk-Based Approach to Management of Leachables Utilizing Statistical Analysis of Extractables","display_name":"A Risk-Based Approach to Management of Leachables Utilizing Statistical Analysis of Extractables","publication_year":2014,"publication_date":"2014-10-07","ids":{"openalex":"https://openalex.org/W2054444951","doi":"https://doi.org/10.1208/s12249-014-0221-9","mag":"2054444951","pmid":"https://pubmed.ncbi.nlm.nih.gov/25294001","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4370972"},"language":"en","primary_location":{"id":"doi:10.1208/s12249-014-0221-9","doi":"https://doi.org/10.1208/s12249-014-0221-9","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12249-014-0221-9","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12249-014-0221-9.pdf","source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1208/s12249-014-0221-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089742992","display_name":"Cheryl L. M. Stults","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheryl L. M. Stults","raw_affiliation_strings":["Novartis Pharmaceuticals Corp, San Carlos, California, USA","Novartis Pharmaceuticals Corporation, San Carlos, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corp, San Carlos, California, USA","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, San Carlos, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009879675","display_name":"Jaromir Mikl","orcid":"https://orcid.org/0000-0002-5658-9809","observed_orcids":["https://orcid.org/0000-0002-5658-9809"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaromir Mikl","raw_affiliation_strings":["Boehringer Ingelheim, Ridgefield, Connecticut, USA","Boehringer-Ingelheim, Ridgefield, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim, Ridgefield, Connecticut, USA","institution_ids":["https://openalex.org/I4210160255"]},{"raw_affiliation_string":"Boehringer-Ingelheim, Ridgefield, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090644367","display_name":"Oliver P. Whelehan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Oliver Whelehan","raw_affiliation_strings":["GlaxoSmithKline, Brentford, Middlesex, UK","GlaxoSmithKline Brentford UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Brentford, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline Brentford UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113572779","display_name":"Bradley D. Morrical","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Bradley Morrical","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073888959","display_name":"William Duffield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Duffield","raw_affiliation_strings":["Novartis Pharmaceuticals Corp, San Carlos, California, USA","Novartis Pharmaceuticals Corporation, San Carlos, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corp, San Carlos, California, USA","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, San Carlos, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073188296","display_name":"Lee M. Nagao","orcid":"https://orcid.org/0009-0004-7630-3929","observed_orcids":["https://orcid.org/0009-0004-7630-3929"]},"institutions":[{"id":"https://openalex.org/I4210167273","display_name":"Infrared Processing and Analysis Center","ror":"https://ror.org/05q79g396","country_code":"US","type":"facility","lineage":["https://openalex.org/I122411786","https://openalex.org/I4210167273"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lee M. Nagao","raw_affiliation_strings":["IPAC-RS, Drinker Biddle & Reath, LLP, Washington, District of Columbia, 20005, USA","Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPAC-RS, Drinker Biddle & Reath, LLP, Washington, District of Columbia, 20005, USA","institution_ids":["https://openalex.org/I4210167273"]},{"raw_affiliation_string":"Washington, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5073188296"],"corresponding_institution_ids":["https://openalex.org/I4210167273"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":0.5935,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.61197563,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"16","issue":"2","first_page":"315","last_page":"326"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leachables","display_name":"leachables","score":0.9789999723434448},{"id":"https://openalex.org/keywords/extractables","display_name":"extractables","score":0.9409999847412109},{"id":"https://openalex.org/keywords/risk-based-management","display_name":"risk-based management","score":0.7139999866485596},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.9779999852180481},{"id":"https://openalex.org/keywords/injection-molding","display_name":"injection molding","score":0.902999997138977},{"id":"https://openalex.org/keywords/molding-process-parameters","display_name":"molding parameters","score":0.8740000128746033},{"id":"https://openalex.org/keywords/anova-models","display_name":"ANOVA models","score":0.597000002861023},{"id":"https://openalex.org/keywords/process-optimization","display_name":"process optimization","score":0.4779999852180481},{"id":"https://openalex.org/keywords/container-closure-systems","display_name":"container closure systems","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5679904222488403},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.5478061437606812},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5452937483787537},{"id":"https://openalex.org/C67558686","wikidata":"https://www.wikidata.org/wiki/Q1770806","display_name":"Molding (decorative)","level":2,"score":0.533481240272522},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.4995415210723877},{"id":"https://openalex.org/C2781018962","wikidata":"https://www.wikidata.org/wiki/Q5164884","display_name":"Container (type theory)","level":2,"score":0.4604296386241913},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.4530181884765625},{"id":"https://openalex.org/C168167062","wikidata":"https://www.wikidata.org/wiki/Q1117970","display_name":"Component (thermodynamics)","level":2,"score":0.425251841545105},{"id":"https://openalex.org/C200601418","wikidata":"https://www.wikidata.org/wiki/Q2193887","display_name":"Reliability engineering","level":1,"score":0.3561970889568329},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2311464548110962},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.18178802728652954},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.181321382522583},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.1065419614315033},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0},{"id":"https://openalex.org/C2776207758","wikidata":"https://www.wikidata.org/wiki/Q5303302","display_name":"Downstream (manufacturing)","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004340","descriptor_name":"Drug Contamination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004349","descriptor_name":"Drug Packaging","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D009330","descriptor_name":"Nebulizers and Vaporizers","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1208/s12249-014-0221-9","doi":"https://doi.org/10.1208/s12249-014-0221-9","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12249-014-0221-9","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12249-014-0221-9.pdf","source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3573224","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4370972","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:25294001","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25294001","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4370972","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4370972/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1208/s12249-014-0221-9","doi":"https://doi.org/10.1208/s12249-014-0221-9","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12249-014-0221-9","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12249-014-0221-9.pdf","source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Responsible consumption and production","score":0.807699978351593,"id":"https://metadata.un.org/sdg/12"},{"display_name":"Good health and well-being","score":0.4000000059604645,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2054444951.pdf","grobid_xml":"https://content.openalex.org/works/W2054444951.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W578855318","https://openalex.org/W2043134556","https://openalex.org/W2044771513","https://openalex.org/W2057415115","https://openalex.org/W2134517079","https://openalex.org/W2475826984","https://openalex.org/W2928034868"],"related_works":["https://openalex.org/W2809417807","https://openalex.org/W3215205181","https://openalex.org/W2128456909","https://openalex.org/W2160257914","https://openalex.org/W7168165906","https://openalex.org/W3198418956","https://openalex.org/W3156632868","https://openalex.org/W7124925459","https://openalex.org/W4387782206","https://openalex.org/W1980429139"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}